Market cap is the total market value to buy the whole company. Rewards. View and export this data going back to 2007. Market Cap $278.06B; Shares Outstanding N/A; Public Float 5.54B; Beta N/A; Rev. Market cap is the total market value to buy the whole company. Roche’s non-voting equity securities and the rights pertaining thereto are described in §4ss. The increasing trend continued in the third quarter of the year, with the figure growing to $904.1bn last week. Earnings are forecast to grow 7.9% per year. Since 2018, Roche has added about 120B to their market cap. ... Market Cap. If Roche issued shares to buy Gilead, it would set them back less than two years of gains. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. The company’s 50 day simple moving average is $43.60 and its 200-day simple moving average is $43.27. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth. Please check your download folder. Roche Holding AG a un bêta 0.88. Fundamental Analysis Info: Britain is in talks with Swiss drugmaker Roche Holding AG (ROG.S) to buy an accurate COVID-19 antibody test, following the lead of the European Union and United States, which had already given preliminary approval to … This makes Roche the world's 28th most valuable company by market cap according to our data. Stock Advisor Flagship service. Market Cap for Roche Holding AG. The Company distributes its products throughout Europe, the United States, Asia and Latin America. Sean Rai-Roche is a Reporter for Clinical Trials Arena parent company GlobalData’s investigative journalism team. Real time Roche Holding Ltd. (ADR) (RHHBY) stock price quote, stock graph, news & analysis. Market data delayed by 15 min, provided by Fides delivered by QUARTAL FLIFE. Current and historical earnings charts for Roche. Security Trading Reuters Bloomberg SIX Swiss Exchange ISIN; Roche bearer share: SIX: RO.S: RO SW: RO: CH0012032113: Roche NES: SIX: ROG.S: ROG SW: ROG: CH0012032048: Roche ADR: OTCQX: RHHBY: RHHBY--Capital Structure. The company valuation of Roche Holding AG according to these metrics is below the market valuation of its peer group. Sign In. Start your Free Trial. The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. As of March 2021 Roche's TTM earnings are $0 M As of March 2021 Roche's TTM earnings are $0 M companies: 4,755 total market cap: $84.868 T Find real-time RHHBY - Roche Holding AG stock quotes, company profile, news and forecasts from CNN Business. Part 4 - Gilead is Insanely Undervalued A breakdown of Gilead’s market cap. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. The firm has a market cap of $281.47 billion, a PE ratio of 16.18, a price-to-earnings-growth ratio of 3.69 and a beta of 0.35. Ceci est légèrement inférieur à 1. Compare RHHBY With Other Stocks La volatilité de Roche Holding AG d'après ce critère est légèrement inférieure à la volatilité du marché. View and export this data going back to 2007. Roche (RHHBY) 2020 Earnings Down Due to Biosimilars, COVID-19. Export Data Save Image Print Image For advanced charting, view our full-featured Fundamental Chart. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Already a subscriber? Market Cap Revenue; Medical: Large Cap Pharmaceutical: $278.460B: $64.542B: Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. RHHBF: Get the latest Roche stock price and detailed information including RHHBF news, historical charts and realtime prices. Sign in. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. To access more articles like this, visit GlobalData. Roche’s American Depositary Receipt (ADR) is listed on OTCQX International Premier under the ticker RHHBY. Roche has a 12-month low of $35.04 and a 12-month high of $47.15. Please try again by refreshing your browser or contact us with details of your problem. Fundamental Analysis Info: Britain is in talks with Swiss drugmaker Roche Holding AG (ROG.S) to buy an accurate COVID-19 antibody test, following the lead of the European Union and United States, which had already given preliminary approval to … Get the tools used by (smart) 2 investors. Historical Market Cap Data. GLAX.F 4.8% DSKY.F 4.5% NONO.F -2.0% AZNC.F 1.8% NVSE.F 1.7% | SP500 0.1% DOW 0.5% NASDAQ -0.7%. Stock analysis for Roche Holding AG (RHHBF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. Roche eliminates 474 positions Jul. This would net them 20 years worth of pipeline with drugs from Gilead oncology acquisitions, like Kite and Immunomedics. Search. The market is bullish and the idea is to invest in the Market direction. Get Started. Type Number; Number of bearer shares (nominal value … Trading at 60.5% below our estimate of its fair value. Day Range. News. Watchlists Ideas Screener Data Explorer Templates Charts Saved Work. More Details. In most cases it can be easily calculated by multiplying the … Earnings for Roche (RHHBY) Earnings in 2019: $19.53 B In 2019 the company made an earning of $19.53 B an increase over its 2018 earnings that were of $16.71 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT. There is no data for the selected date range. S&P. Executive Summary. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. 281.114B. Company Financials + 19 Analysts. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascual and Metabolism, Opthamology and Respiratory branches Medicines. 2021/03/22 18:07 UTC. Roche Holding’s revenue grew at a CAGR of 5.3% from $52.5 billion in 2015 to $64.4 billion in 2019, and it is estimated to top $66 billion in 2020, led by its Neuroscience drugs. Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. Market Cap: ~$230B Headquarter: Basel, Switzerland . View 4,000+ financial data types. Roche has a focus on multiple therapy areas including ophthalmology, oncology and immunology. More information about the Roche ADR. ... Market cap: $224.3B: Data as of 03/26/2021. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Roche Market Cap: 276.07B for March 26, 2021. Roche Holding AG Market Cap 2006-2020 | RHHBY. The market is bullish and the idea is to invest in the Market direction. An error occurred. of the Articles of Incorporation of Roche Holding Ltd. For more information, please read the Articles of Incorporation. Roche Holding has a market cap of $287.29 B, which represents its current share price of $41.95 multiplied by its outstanding share number of 6848.49. Latest Stock Picks Investing Basics Premium Services. Roche Holding AG market cap history and chart from 2006 to 2020. Browse... View Full Chart Market Cap Chart . In depth view into Roche Market Cap including historical data from 2001, charts, stats and industry comps. 30, 2020 at 11:15 a.m. Investigates Sale of GNMK and Encourages Investors to Contact the Firm, Roche's Actemra + Remdesivir study flunks late-stage COVID-19 study, Natera and Genentech initiate late-stage muscle-invasive bladder cancer trial, FDA OKs expanded use of Roche's Ventalan ALK Assay in lung cancer, Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib), Genentech pulls back U.S. indication for Tecentriq in bladder cancer, FDA OKs Roche's Actemra injection for regulating pulmonary function in SSc-ILD, Dicerna and Roche start mid-stage Hepatitis B RG6346 trial, Roche teams up with Tempest Therapeutics in liver cancer study, Adaptive Biotech downgraded by Goldman Sachs on Genentech exit, Regeneron's antibody cocktail is set for marketing approval in EU. Find the latest ROCHE GS (ROG.SW) stock quote, history, news and other vital information to help you with your stock trading and investing. Press Releases . Stock analysis for Roche Holding AG (RHHBF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. CHF264.2b. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. Roche has a market cap of USD 267.81bn (18 February). The P/Earnings NTM ratio of Roche Holding AG is lower than the median of its peer group: around 19.00. Kolabtree. ET by Jaimy Lee Roche's rheumatoid arthritis drug fails in COVID-19 trial Roche's market cap is $309.6 billion... View Roche Holding AG's Market Cap trends, charts, and more. 10 offres d'emploi - La Roche-sur-Foron (74) - Carrefour / Carrefour Market - Bac+3, CAP, Autodidacte, Bac+6 et plus, Bac+2 sur Distrijob, le site emploi Retail et Distribution. Market cap: 297.06B: Beta (5Y monthly) 0.22: PE ratio (TTM) N/A: EPS (TTM) N/A: Earnings date: N/A: Forward dividend & yield: 1.14 (2.59%) Ex-dividend date: 19 Mar 2020: 1y target est: 48.51: All. Return. Market Cap. Real time Roche Holding Ltd. (ADR) (RHHBY) stock price quote, stock graph, news & analysis. To buy Gilead for $90/share, they would only need about 113B. Zacks. Stock analysis for Roche Holding AG (ROG:SIX Swiss Ex) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Roche is a Swiss multinational healthcare company operating worldwide under pharmaceuticals and diagnostics divisions. View the latest Roche Holding AG (ROG) stock price, news, historical charts, ... Market Capitalization Reflects the total market value of a company. As of March 2021 Roche has a market cap of $279.34 B. Collapse. Market cap is the total market value to buy the whole company. Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. Last Updated. There is 99.999999999% chance that Gilead and Roche employees are reading our merger articles. Roche Holding’s revenue grew at a CAGR of 5.3% from $52.5 billion in 2015 to $64.4 billion in 2019, and it is estimated to top $66 billion in 2020, led by its Neuroscience drugs. Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. Roche Holding has a market cap of $274.56 B, which represents its current share price of $40.09 multiplied by its outstanding share number of 6848.49. Roche is the world's number 1 in biotech with 17 biopharmaceuticals on the market. Roche Holding AG market cap as of March 17, 2021 is $287.98B. Atea Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Update, iTeos Therapeutics shares rise 4% as Wedbush ups price target, Ionis Pharma gets positive views from analysts; slide extends to developers on HT, Drug pricing legislation introduced by Sanders weighs on pharmas, Ionis viewed favorably despite trial setback; BioLife Solutions upgraded at Benchmark in today’s analyst action, Regeneron's COVID-19 antibody reduces hospitalization, death by 70%, Ionis announces discontinuation of Huntington's disease studies, Genentech's Tecentriq meets late-stage lung cancer study main goal, GENMARK ALERT: Bragar Eagel & Squire, P.C. Symbols. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. A version of this article originally appeared on the Insights module of GlobalData’s Pharmaceutical Intelligence Center. Market Cap Revenue; Medical: Large Cap Pharmaceutical: $278.460B: $64.542B: Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. Statistics show during the second quarter of 2020, the combined market cap of Johnson&Johnson, Roche Holding and Novartis rose to $868.3bn, a $51.2bn jump in three months. per Employee $612.40K; P/E Ratio 18.44; EPS $2.19; Yield 1.91%; Dividend $1.22; Ex … Roche Holding AG market cap as of March 30, 2021 is. Data Sources. Share. Related Companies. Growth & Valuation. Please check your download folder. For advanced charting, view our full-featured. RHHBF: Get the latest Roche stock price and detailed information including RHHBF news, historical charts and realtime prices.